Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).
Montalescot G, Bal-dit-Sollier C, Chibedi D, Collet JP, Soulat T, Dalby M, Choussat R, Cohen A, Slama M, Steg PG, Dubois-Randé JL, Metzger JP, Tarragano F, Guermonprez JL, Drouet L; ARMADA Investigators. Montalescot G, et al. Among authors: dalby m. Am J Cardiol. 2003 Apr 15;91(8):925-30. doi: 10.1016/s0002-9149(03)00105-x. Am J Cardiol. 2003. PMID: 12686329 Clinical Trial.
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study.
Dalby M, Montalescot G, Bal dit Sollier C, Vicaut E, Soulat T, Collet JP, Choussat R, Gallois V, Drobinski G, Drouet L, Thomas D. Dalby M, et al. J Am Coll Cardiol. 2004 Jan 21;43(2):162-8. doi: 10.1016/j.jacc.2003.08.033. J Am Coll Cardiol. 2004. PMID: 14736431 Free article. Clinical Trial.
Transfer for primary angioplasty: who and how?
Dalby M, Montalescot G. Dalby M, et al. Heart. 2002 Dec;88(6):570-2. doi: 10.1136/heart.88.6.570. Heart. 2002. PMID: 12433880 Free PMC article. Review.
Prognosis of moderate coronary artery lesions in heart transplant patients.
Luyt CE, Drobinski G, Dorent R, Ghossoub JJ, Collet JP, Choussat R, Dalby M, Thomas D, Gandjbakhch I. Luyt CE, et al. Among authors: dalby m. J Heart Lung Transplant. 2003 Feb;22(2):130-6. doi: 10.1016/s1053-2498(02)00491-6. J Heart Lung Transplant. 2003. PMID: 12581760
Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.
Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP. Gershlick AH, et al. Among authors: dalby m. J Am Coll Cardiol. 2015 Mar 17;65(10):963-72. doi: 10.1016/j.jacc.2014.12.038. J Am Coll Cardiol. 2015. PMID: 25766941 Free PMC article. Clinical Trial.
Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy.
McCann GP, Khan JN, Greenwood JP, Nazir S, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH. McCann GP, et al. Among authors: dalby m. J Am Coll Cardiol. 2015 Dec 22;66(24):2713-2724. doi: 10.1016/j.jacc.2015.09.099. J Am Coll Cardiol. 2015. PMID: 26700834 Free PMC article. Clinical Trial.
Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial.
Gershlick AH, Banning AS, Parker E, Wang D, Budgeon CA, Kelly DJ, Kane PO, Dalby M, Hetherington SL, McCann GP, Greenwood JP, Curzen N. Gershlick AH, et al. Among authors: dalby m. J Am Coll Cardiol. 2019 Dec 24;74(25):3083-3094. doi: 10.1016/j.jacc.2019.10.033. J Am Coll Cardiol. 2019. PMID: 31856964 Free article. Clinical Trial.
416 results